remain bullish ci follow result mark solid core trend
on-going cost manag attract growth opportun strong cf
rais full year guidanc esrx integr track sell season
result look good came modestli ahead expect
strong trends/mcr expect remain stabl see attract
cross-sel opportun expect ramp government sector growth reiter
buy rate price target adjust ep continu
like view compel risk/reward
guidanc rais post strong result
stronger top line solid cost manag drove adjust ep
well ahead consensu adjust revenu
best aid stronger pharmaci revenu mcr
ahead consensu mcr rang
reiter delta driven three factor
 hif inclus esrx busi higher
mcr individu known about/discuss previous health servic
result improv nice sequenti singl digit expect y/
came bit ahead intern expect sg vs strhe
came well ahead estim increas efficiencies/improv
leverage/strong result aid drove better full-year expect
vs prior also benefit favor
tax item compani rais full year guidanc adjust revenu
 vs prior includ transit
pharmaci script volum optumrx adjust pharmaci script
 adjust ep
 vs prior medic membership growth guidanc detail
cut midpoint
vs margin bp came modestli ahead
intern expect continu see sever factor drive
acceler growth back half year suppli chain initi
specialti growth gener synergi think segment set
grown custom base compani
rais full year adjust script count guidanc
narrow up lower end expect sell season
tr target
retent rate specialti remain fastest growth pharma cost segment key
area client focu compani continu see robust growth differenti offer
accredo comprehens offer subspecialti pharmaci trc safeguardrx evicor
customiz approach increasingli reson given rapidli rise specialti cost chronic
diseas preval strong np score approach clinic coordin program
home/field nurs best class specialti pharmaci expect strong specialti growth
membership yoy on-going strength select segment off-set declin
nation account modest deterior top end middl market compani
saw rfp volum cycl result bit nation account churn high end
market tend client leverag ci integr offer lesser degre medic
cost trend remain stabl mcr higher anticip guidanc
reiter driven aforement previous disclos area manag reiter
full year cost trend expect commerci book final
plan expand go deep market next year view
meaning opportun like multi-year growth tailwind addit see attract cross-
sell opportun product line geograph given synergist offer limit
offer strong qualiti rate expertis manag high cost chronic popul view
compani tee success govern busi expect increas
contributor time reiter long term membership growth target within medicar
advantag lower end expect estim call
fuel geograph product expans includ roll-out new ppo product
expect launch market next year given cigna strong specialti platform field
nurs diseas specif expertis trc evicor attract qualiti rate member
plan higher high level clinic collabor expertis highli complex
chronic view compani well posit outsiz growth multi-year period
see signific run room govern segment
integr remain track compani pois deliv synergi target
earn per share continu see meaning benefit integr offer
convict power combin platform remain high addit increas care
coordin improv outcom reduc cost think integr pharmacy/med
platform offer superior posit look provid total patient care expand in-home/
field nurs offer also bring number benefit includ increment patient touch point
insight patient home set dovetail nice compani abil address
social determin particularli complex popul also see signific valu
accredo offer esrx scale mail capabl value-driven environ given adher
benefit abil close gap care increas connect multipl lever drive overal
cost provid high qualiti
detail updat estim cffo came ahead estim
compani repaid debt compani exit debt-to-cap ratio
track achiev target goal high end expect pay
debt share buy-back activ remain on-going share repurchas
compani bought back date expect total buy-back capac
year continu like capit effici model expect on-going strong free cash flow
gener estim call cffo rais
estim reflect result
updat guidanc ep unchang reiter buy rate price
target adjust ep remain favorit risk/reward play
page
 group disabl premium
total revenu
revenu
revenu
compani document suntrust robinson humphrey estim exclud one-tim charg transit client adjust add back
revenu reflect transit client exclud
page
provid health servic global four divis integr medic
group disabl integr medic offer medic solut across broad
rang market commerci govern integr offer local focu
segment provid pharmaci medic manag servic includ major
legaci express script busi group disabl cover group disabl life
product intern divis cover varieti product servic intern
market employe multi-n compani
reiter buy rate ci see signific on-going opportun across busi would
expect compani highli integr value-bas approach continu reson market
look on-going share gain addit think strategic/financi benefit recent
esrx deal underappreci view valuat risk/reward compel
valuat risk
trade ep meaning discount manag care group averag tie
larg view discount industri concern appreci valu
recent acquisit esrx like compani integr offer attract absolute/rel
medic trend strong cash flow clinic capabl price target base ci trade
ep premium current multipl view appropri given attract growth
opportun across broad rang area risk includ exposur commerci market
view less attract growth prospect vs govern pay meaning membership
attrit recent sizabl esrx acquisit bring integr risk
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
